Evidence map›Paper›PMID 41280882›Full record

ArticleFrontiers in artificial intelligence2025

LLMCARE: early detection of cognitive impairment via transformer models enhanced by LLM-generated synthetic data.

Ali Zolnour, Hossein Azadmaleki, Yasaman Haghbin, Fatemeh Taherinezhad, Mohamad Javad Momeni Nezhad, Sina Rashidi, Masoud Khani, AmirSajjad Taleban, Samin Mahdizadeh Sani, Maryam Dadkhah and 6 more

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ali ZolnourColumbia University Irving Medical Center, New York, NY, United States.
Hossein AzadmalekiColumbia University Irving Medical Center, New York, NY, United States.
Yasaman HaghbinColumbia University Irving Medical Center, New York, NY, United States.
Fatemeh TaherinezhadColumbia University Irving Medical Center, New York, NY, United States.
Mohamad Javad Momeni NezhadColumbia University Irving Medical Center, New York, NY, United States.
Sina RashidiColumbia University Irving Medical Center, New York, NY, United States.
Masoud KhaniUniversity of Wisconsin-Milwaukee, Milwaukee, WI, United States.
AmirSajjad TalebanUniversity of Wisconsin-Milwaukee, Milwaukee, WI, United States.
Samin Mahdizadeh SaniSchool of Electrical and Computer Engineering, University of Tehran, Tehran, Iran.
Maryam DadkhahColumbia University Irving Medical Center, New York, NY, United States.
James M NobleColumbia University Irving Medical Center, New York, NY, United States.
Suzanne BakkenSchool of Nursing, Columbia University, New York, NY, United States.
Yadollah YaghoobzadehSchool of Electrical and Computer Engineering, University of Tehran, Tehran, Iran.
Abdol-Hossein VahabieSchool of Electrical and Computer Engineering, University of Tehran, Tehran, Iran.
Masoud RouhizadehCollege of Pharmacy, University of Florida, Gainesville, FL, United States.
Maryam ZolnooriColumbia University Irving Medical Center, New York, NY, United States.

Funding

Research Education CoreP30AG066462 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PHILIP L DE JAGER · 2020 to 2026
$30.1M
Research Education CoreP30AG059303 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Jennifer Jaie Manly · 2018 to 2026
$6.0M
Development of a Screening Algorithm for Timely Identification of Patients with Mild Cognitive Impairment and Early Dementia in Home HealthcareR00AG076808 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Maryam Zolnoori · 2024 to 2026
$742k
NIA NIH HHS P30 AG059303NIA NIH HHS P30 AG066462NIA NIH HHS R00 AG076808
6 · The paper itself

Abstract

Background: Alzheimer's disease and related dementias (ADRD) affect nearly five million older adults in the United States, yet more than half remain undiagnosed. Speech-based natural language processing (NLP) provides a scalable approach to identify early cognitive decline by detecting subtle linguistic markers that may precede clinical diagnosis. Objective: This study aims to develop and evaluate a speech-based screening pipeline that integrates transformer-based embeddings with handcrafted linguistic features, incorporates synthetic augmentation using large language models (LLMs), and benchmarks unimodal and multimodal LLM classifiers. External validation was performed to assess generalizability to an MCI-only cohort. Methods: Transcripts were obtained from the ADReSSo 2021 benchmark dataset ( Results: On the ADReSSo dataset, the fusion model achieved an F1-score of 83.32 (AUC = 89.48), outperforming both transformer-only and linguistic-only baselines. Augmentation with MedAlpaca-7B synthetic speech improved performance to F1 = 85.65 at 2 × scale, whereas higher augmentation volumes reduced gains. Fine-tuning improved unimodal LLM classifiers (e.g., MedAlpaca-7B, F1 = 47.73 → 78.69), while multimodal models demonstrated lower performance (Phi-4 = 71.59; GPT-4o omni = 67.57). On the Delaware corpus, the pipeline generalized to an MCI-only cohort, with the fusion model plus 1 × MedAlpaca-7B augmentation achieving F1 = 72.82 (AUC = 69.57). Conclusion: Integrating transformer embeddings with handcrafted linguistic features enhances ADRD detection from speech. Distributionally aligned LLM-generated narratives provide effective but bounded augmentation, while current multimodal models remain limited. Crucially, validation on the Delaware corpus demonstrates that the proposed pipeline generalizes to early-stage impairment, supporting its potential as a scalable approach for clinically relevant early screening. All codes for LLMCARE are publicly available at: GitHub.

Indexed as

Alzheimer’s diseasedata augmentationlarge language modelsmild cognitive impairment (MCI)natural language processingtransformers

Identifiers

PMID41280882
PMCPMC12631619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.